GM26181
LCL from B-Lymphocyte
Description:
NEMALINE MYOPATHY 2, AUTOSOMAL RECESSIVE; NEM2
NEBULIN; NEB
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific PIGI Consented Sample |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Country of Origin
|
USA
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
NEB |
Chromosomal Location |
2q23.3 |
Allelic Variant 1 |
Frameshift; NEMALINE MYOPATHY 2; NEM2 |
Identified Mutation |
c.24313_24317dupGTGTT; This variant is predicted to result in a frameshift and premature protein termination. |
|
Gene |
NEB |
Chromosomal Location |
2q23.3 |
Allelic Variant 1 |
Splicing defect; NEMALINE MYOPATHY 2; NEM2 |
Identified Mutation |
c.5238+1G>A; This variant lies in the canonical donor splice site at the exon/intron border. Prediction programs indiciate variant will completely abolish the donor splice site and likely result in aberrant splicing. |
Remarks |
Clinically affected with congenital nemaline rod myopathy; holds head up, sits and walks without assistance and has maintained these motor functions; subject has never been able to run; diagnosis has been confirmed by muscle biopsy, muscle imaging, and Nextgen sequencing with a congenital myopathy panel; normal brain MRI; donor is heterozygous in the NEB gene for two likely pathogenic variants: c.5238+1G>A (predicted to completely abolish the donor splice site and likely result in aberrant splicing) and c.24313_24317dupGTGTT (predicted to result in a frameshift and premature protein termination p.Tyr8107Cysfs*75); based on the data from several prediction programs, both variants are expected to be pathogenic. |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|